alfresa -Alfresa Pharma Corporation-

For many people

For one person

As long as there are

Through the entire healthcare process, from diagnosis, to treatment, to prevention

Research and development, production, sales, Contract Manufacturing

From Japan to the world

From the world to Japan

For the health of all the world's people We are taking on the challenge of Unmet Medical Needs

2018/11/05: Financial Results Summary for the Second Quarter Ended September 30, 2018

2018/11/05: Summary of Consolidated Financial Statements for the Second Quarter Ended September 30, 2018

2018/10/29: Notice Regarding Revision to Consolidated Performance Forecast

2018/08/03: Financial Results Summary for the First Quarter Ended June 30, 2018

2018/08/03: Summary of Consolidated Financial Statements for the First Quarter Ended June 30, 2018

: Company Information Index; President Message; Profile; Basic Philosophy; Production System; Reliability Assurance System; Financial Statementes

: Business Domain Index; Pharmaceuticals; Diagnostic Reagents; Medical Devices & Equipment; Overseas Sales; API Sales; Contract Manufacturing